Objectives: Reconstruction of long segmental tracheal defects is difficult because no ideal tracheal substitutes are currently available. Tracheal allotransplantation maintains cartilage and epithelium viability but requires immunosuppression because of epithelial immunogenicity. We aimed to obtain an epithelium-decellularized allograft that maintains cartilage viability and to evaluate long-term outcomes of such allografts implanted on dog backs without immunosuppressants.
Methods: Twenty-five tracheas harvested from mongrel dogs were used to explore the period of epithelium decellularization by combined use of 1% sodium dodecyl sulfate and an organ preservation solution and to assess the chondrocyte viability and immunogenicity of the tracheas after decellularization. Sixteen epithelium-decellularized tracheal allografts and 10 fresh tracheal segments (6 cm long) were implanted in 26 beagles for durations of 10 days and 1, 3, 6, and 12 months. Macroscopic and microscopic examinations were used to evaluate the morphology, viability, and immune rejection of the allografts. Safranin-O staining was used to detect glycosaminoglycans.
Results: The epithelium disappeared after 24 hours of decellularization. At 72 hours, almost no nuclei remained in the mucosa, while the mean survival rate of chondrocytes was 88.1%. Histological analysis demonstrated that the allograft retained intact tracheal rings and viable cartilage after heterotopic implantation for 1 year, with no immunological rejection. There were no significant differences in the glycosaminoglycan contents among the implanted epithelium-decellularized allografts.
Conclusions: Epithelium-decellularized tracheal allografts with chondrocyte viability can be achieved by combined use of a detergent and organ preservation solution, which showed satisfactory cartilage viability and structural integrity after long-term heterotopic transplantation. Further studies on orthotopic transplantation are needed to assess the feasibility of allografts in reconstructing long segmental tracheal defects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0003489420957357 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-term survival after tracheal replacement using a cryopreserved aortic allograft.
JTCVS Tech
December 2024
Department of Thoracic and Endocrine Surgery, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France.
[Vascularized composite allografts in France: An update].
Ann Chir Plast Esthet
December 2024
Department of Plastic and Reconstructive Surgery, Institut Universitaire Locomoteur et du Sport, Pasteur 2 Hospital, University Côte d'Azur, Nice, France.
Vascularized composite allografts (VCA) encompass the face, upper limb, trachea, penis, abdominal wall, and, more recently, uterus transplants. They offer unique reconstructive possibilities to overcome the limitations of traditional reconstructive techniques. Unlike solid organ transplants (heart, liver, kidney, lung, etc.
View Article and Find Full Text PDFAssessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome.
Transpl Int
November 2024
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Article Synopsis
- - Bronchiolitis obliterans syndrome (BOS) is a serious complication after lung transplants that affects long-term survival, and this study explores the role of EZH2 in BOS.
- - The research involved administering a drug called 3-deazaneplanocin A (DZNep) to mice with transplanted tracheas, showing that DZNep significantly reduced obstruction ratios and levels of various inflammatory cytokines at different time points.
- - Results indicated that DZNep treatment decreased T-cell infiltration and inflammatory responses, suggesting its potential as a therapy to mitigate BOS symptoms post-lung transplantation.
Tracheal transplantation: lessons learned that may apply to lung transplantation.
Curr Opin Organ Transplant
December 2024
Institute for Airway Sciences, Co-Scientific Director, Center for Epithelial and Airway Biology and Regeneration, Basic Science Research, Otolaryngology, Director, Developmental Origins of Health and Disease, Department of Otolaryngology, Department of Cell, Developmental and Regenerative Biology, Department of Pathology, Molecular and Cell Based Medicine, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Purpose Of Review: The purpose of this review is to explore the lessons learned from experimental and human tracheal transplantation to determine if this information may be applied to lung transplantation.
Recent Findings: Experimental work in animal models and the recent human tracheal transplantation suggests that a robust tracheal vascular supply prevents anastomotic complications. Further, this work demonstrates that tracheal allografts undergo a progressive chimerism as recipient epithelium repopulates the allograft.
Revolutionizing tracheal reconstruction: innovations in vascularized composite allograft transplantation.
Front Bioeng Biotechnol
August 2024
Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
Tracheal defects, particularly those extending over long segments, present substantial challenges in reconstructive surgery due to complications in vascularization and integration with host tissues. Traditional methods, such as extended tracheostomies and alloplastic stents, often result in significant morbidity due to mucus plugging and mechanical erosion. Recent advances in vascularized composite allograft (VCA) transplantation have opened new avenues for effective tracheal reconstruction.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!